Cardiac Transplant
Conditions
Keywords
Transplant, Cytokines, Graft Dysfunction
Brief summary
Measurement of cytokine levels in post-cardiac transplant patients with unexplained graft dysfunction.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
Group 1 * 18 years and older * Cardiac Transplant recipient with graft dysfunction of unknown etiology Group 2 * 18 years or older * No history of heart failure or cardiac transplantation Group 3 * 18 years or older * Class II-IV heart failure Group 4 * 18 years or older * Heart Transplant 6 months or greater prior to blood draw * No graft dysfunction
Exclusion criteria
Group 1 Heart Transplant with Unexplained Graft Dysfunction * Cellular or antibody-mediated cardiac allograft dysfunction Group 2 Normal Control group * Active infection within 1 month of blood draw * Known Inflammatory Disease Group 3 Heart Failure Group * Active infection within 1 month of blood draw * Known Inflammatory Disease Group 4 Heart Transplant with Normal Graft Function Group * Active infection within 1 month of blood draw * Known graft dysfunction * Known Inflammatory Disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Differences in cytokine profiles between stable heart transplant recipients and those with acute rejection | 12 months | Differences in cytokine profiles between stable heart transplant recipients and those with acute rejection |